YMC Co., Ltd. (“YMC”), a leading supplier of separation resins, services and systems for the pharmaceutical market, has acquired all shares in ChromaCon AG (Zurich, Switzerland) and executed the transfer of 100% shares in the Company on April 1st , 2019.
ChromaCon AG, a life science tool company, is a leader in continuous chromatography technologies. ChromaCon markets laboratory-scale purification systems employing its process technologies, process simulation and operating software. ChromaCon has pioneered twin-column purification, significantly increasing productivity in large biopharmaceutical) and small (pharmaceutical) molecule manufacturing, thereby reducing operational cost. YMC and ChromaCon have been cooperating in Japan and India for the marketing & sale of ChromaCon’s lab-scale systems. In addition, ChromaCon has licensed proprietary technologies to YMC Process Technologies (“YPT”) for GMP production scale equipment. YMC completed its acquisition of YPT from LEWA-Nikkiso America in December 2018. YPT develops and manufactures pilot- and production-scale separation systems for the (bio-)pharmaceutical manufacturing industry.
Michael Bavand, CEO of ChromaCon, commented: “We have been working productively with YPT in development, launch and co-marketing of continuous chromatography pilot/production systems during the past three years achieving a market pole position in industrial implementation of our technology with key customers. We are looking forward to intensifying our interactions being part of the YMC Group of Companies. The acquisition of ChromaCon will benefit our customers ensuring a seamless transfer of our business relationship, technologies and products to YMC.”
Potential questions and answers around the transaction are attached. Further information can be requested from both ChromaCon and YMC.